Lafferty L - Search Results

1

Client and staff perceptions of acceptability of MyCheck: a direct-to-pathology telehealth and e-testing service for comprehensive bloodborne virus and sexually transmissible infection screening.

Lafferty L, Rautenbach C, McNulty A, Ryder N, Slattery C, Houghton R, Kenigsberg A, Murray C, Carrington N, Patel P. Lafferty L, et al. Sex Health. 2024 Apr;21:SH23194. doi: 10.1071/SH23194. Sex Health. 2024. PMID: 38683938

2

The 'missing' in the 'endgame' of hepatitis C elimination: A qualitative study in New South Wales, Australia.

Treloar C, Lancaster K, Rhodes T, Lafferty L, Bryant J, Rance J. Treloar C, et al. Among authors: lafferty l. Drug Alcohol Rev. 2024 Apr 10. doi: 10.1111/dar.13845. Online ahead of print. Drug Alcohol Rev. 2024. PMID: 38596845

3

Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services in Australia.

Lafferty L, Beadman M, Ward J, Flynn E, Hosseini-Hooshyar S, Martinello M, Treloar C. Lafferty L, et al. Int J Drug Policy. 2024 Mar;125:104335. doi: 10.1016/j.drugpo.2024.104335. Epub 2024 Feb 10. Int J Drug Policy. 2024. PMID: 38342050 Free article.

4

Long chain monomethyl branched-chain fatty acid levels in human milk vary with gestational weight gain.

O'Sullivan A, Brady E, Lafferty L, O'Shea F, O'Regan Z, Meurs N, Baldini M, Gengatharan J, Metallo CM, Wallace M. O'Sullivan A, et al. Among authors: lafferty l. Prostaglandins Leukot Essent Fatty Acids. 2024 Jan 22;201:102607. doi: 10.1016/j.plefa.2024.102607. Online ahead of print. Prostaglandins Leukot Essent Fatty Acids. 2024. PMID: 38277883 Free article.

5

'There's too much power in this number. It's freaking the whole response out': The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia.

Treloar C, Rance J, Bryant J, Lafferty L. Treloar C, et al. Among authors: lafferty l. J Viral Hepat. 2024 Feb;31(2):59-65. doi: 10.1111/jvh.13896. Epub 2023 Nov 13. J Viral Hepat. 2024. PMID: 37916576

6

Speed geeking: how speed-dating techniques can tackle power imbalances at conferences.

Lafferty L, Thomas JR, Gare J, Watts CG, Marshall AD. Lafferty L, et al. Nature. 2023 Jun 15. doi: 10.1038/d41586-023-01866-5. Online ahead of print. Nature. 2023. PMID: 37322249 No abstract available.

7

Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study.

Marshall AD, Schroeder SE, Lafferty L, Drysdale K, Baldry E, Stoové M, Dietze P, Higgs P, Treloar C. Marshall AD, et al. Among authors: lafferty l. J Subst Use Addict Treat. 2023 Jul;150:209066. doi: 10.1016/j.josat.2023.209066. Epub 2023 May 6. J Subst Use Addict Treat. 2023. PMID: 37156422

8

A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study.

Sheehan Y, Cunningham EB, Cochrane A, Byrne M, Brown T, McGrath C, Lafferty L, Tedla N, Dore GJ, Lloyd AR, Grebely J. Sheehan Y, et al. Among authors: lafferty l. J Hepatol. 2023 Sep;79(3):635-644. doi: 10.1016/j.jhep.2023.04.019. Epub 2023 Apr 26. J Hepatol. 2023. PMID: 37116714 Clinical Trial.

9

Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.

Wang TY, Wahed AS, Morris A, Kreuziger LB, Quigley JG, Lamas GA, Weissman AJ, Lopez-Sendon J, Knudson MM, Siegal DM, Kasthuri RS, Alexander AJ, Wahid L, Atassi B, Miller PJ, Lawson JW, Patel B, Krishnan JA, Shapiro NL, Martin DE, Kindzelski AL, Leifer ES, Joo J, Lyu L, Pennella A, Everett BM, Geraci MW, Anstrom KJ, Ortel TL; ACTIV-4C Study Group. Wang TY, et al. Ann Intern Med. 2023 Apr;176(4):515-523. doi: 10.7326/M22-3350. Epub 2023 Mar 21. Ann Intern Med. 2023. PMID: 36940444 Free PMC article. Clinical Trial.

10

A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia.

Grebely J, Markus C, Causer LM, Silk D, Comben S, Lloyd AR, Martinez M, Cunningham EB, O'Flynn M, Dore GJ, Matthews S; National Australian Hepatitis C Point-of-Care Testing Program. Grebely J, et al. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):204-207. doi: 10.1016/S2468-1253(22)00355-7. Lancet Gastroenterol Hepatol. 2023. PMID: 36773609 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page